Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene
- *Cecil H. and Ida Green Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235-9051; ‡Harbor-University of California Los Angeles Medical Center, 1000 W. Carson Street, Torrance, CA 90509; and §Prince Henry’s Institute of Medical Research, P.O. Box 5152, Clayton, Victoria 3168, Australia
-
Communicated by Melvin M. Grumbach, University of California, San Francisco, CA (received for review December 19, 1997)
Abstract
The formation of estrogens from C19 steroids is catalyzed by aromatase cytochrome P450 (P450arom), the product of the cyp19 gene. The actions of estrogen include dimorphic anatomical, functional, and behavioral effects on the development of both males and females, considerations that prompted us to examine the consequences of deficiency of aromatase activity in mice. Mice lacking a functional aromatase enzyme (ArKO) were generated by targeted disruption of the cyp19 gene. Male and female ArKO mice were born with the expected Mendelian frequency from F1 parents and grew to adulthood. Female ArKO mice at 9 weeks of age displayed underdeveloped external genitalia and uteri. Ovaries contained numerous follicles with abundant granulosa cells and evidence of antrum formation that appeared arrested before ovulation. No corpora lutea were present. Additionally the stroma were hyperplastic with structures that appeared to be atretic follicles. Development of the mammary glands approximated that of a prepubertal female. Examination of male ArKO mice of the same age revealed essentially normal internal anatomy but with enlargement of the male accessory sex glands because of increased content of secreted material. The testes appeared normal. Male ArKO mice are capable of breeding and produce litters of approximately average size. Whereas serum estradiol levels were at the limit of detection, testosterone levels were elevated, as were the levels of follicle-stimulating hormone and luteinizing hormone. The phenotype of these animals differs markedly from that of the previously reported ERKO mice, in which the estrogen receptor α is deleted by targeted disruption.
Footnotes
-
↵ † Present address: Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Science Center, P.O. Box 1920, 1300 Coulter, Amarillo, TX 79106.
-
↵ ¶ To whom reprint requests should be addressed at: Prince Henry’s Institute of Medical Research, P.O. Box 5152, Clayton, Victoria 3168, Australia. e-mail: evan.simpson{at}med.monash.edu.au.
- ABBREVIATIONS:
- ArKO,
- aromatase-deficient;
- FSH,
- follicle-stimulating hormone;
- LH,
- luteinizing hormone;
- kb,
- kilobase;
- ES,
- embryonic stem
- Copyright © 1998, The National Academy of Sciences








